STOCK TITAN

Salarius Pharmaceuticals (SLRX) 424B Filings

SLRX NASDAQ

Ticker history: SLRX became DCOY (Decoy Therapeutics Inc.) on . Earlier news and filings retain their original names and dates. View SLRX history.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow SLRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SLRX filings page.

Our archive holds no 424B prospectus supplements from Salarius Pharmaceuticals, Inc. over the last 12 months. You will find everything else we hold for the company on the full SLRX filings page.